Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer von AVRIL, Norbert, SASSEN, Stefanie, SCHMALFELDT, Barbara, NAEHRIG, Joerg, RUTKE, Stephan, WEBER, Wolfgang A, WERNER, Martin, GRAEFF, Henner, SCHWAIGER, Markus, KUHN, Walther

Volltext

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer von Jänicke, F, Schmitt, M, Pache, L, Ulm, K, Harbeck, N, Höfler, H, Graeff, H

Volltext

Activation Mechanisms of the Urokinase-type Plasminogen Activator Promoter by Hepatocyte Growth Factor/Scatter Factor von Ried, S, Jäger, C, Jeffers, M, Vande Woude, G F, Graeff, H, Schmitt, M, Lengyel, E

Volltext

Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse von HARBECK, N, THOMSSEN, C, BERGER, U, ULM, K, KATES, R. E, HÖFLER, H, JÄNICKE, F, GRAEFF, H, SCHMITT, M

Volltext

Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression von Wilhelm, Olaf G., Wilhelm, Sabine, Escott, Gemma M., Lutz, Verena, Magdolen, Viktor, Schmitt, Manfred, Rifkin, Daniel B., Wilson, E. Lynette, Graeff, Henner, Brunner, Georg

Volltext

Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87) von Krüger, A, Soeltl, R, Lutz, V, Wilhelm, O G, Magdolen, V, Rojo, E E, Hantzopoulos, P A, Graeff, H, Gänsbacher, B, Schmitt, M

Volltext

Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibit... von Jänicke, Fritz, Prechtl, Anita, Thomssen, Christoph, Harbeck, Nadia, Meisner, Christoph, Untch, Michael, Sweep, C. G. J. Fred, Selbmann, Hans-Konrad, Graeff, Henner, Schmitt, Manfred

Volltext

The Necessity for a Progressing Dialog between Basic Science and Clinical Research in Obstetrics and Gynecology von Graeff, Henner

Volltext

Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian... von Kuhn, Walther, Rutke, Stefan, Späthe, Kerstin, Schmalfeldt, Barbara, Florack, Gerd, von Hundelshausen, Burkhardt, Pachyn, Dmytro, Ulm, Kurt, Graeff, Henner

Volltext

Urokinase receptor localization in breast cancer and benign lesions assessed by in situ hybridization and immunohistochemistry von Hildenbrand, R, Glienke, W, Magdolen, V, Graeff, H, Stutte, H J, Schmitt, M

Volltext

β3A-Integrin Downregulates the Urokinase-Type Plasminogen Activator Receptor (u-PAR) through aPEA3/ets Transcriptional Silencing Element in the u-PAR Promoter von Hapke, Sandra, Gawaz, Meinrad, Dehne, Kerstin, Köhler, Jenny, Marshall, John F., Graeff, Henner, Schmitt, Manfred, Reuning, Ute, Lengyel, Ernst

Volltext

Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose von Avril, Norbert, Dose, Jörg, Jänicke, Fritz, Ziegler, Sibylle, Römer, Wolfgang, Weber, Wolfgang, Herz, Michael, Nathrath, Walter, Graeff, Henner, Schwaiger, Markus

Volltext

β3A-Integrin Downregulates the Urokinase-Type Plasminogen Activator Receptor (u-PAR) through a PEA3/ets Transcriptional Silencing Element in the u-PAR Promoter von Hapke, Sandra, Gawaz, Meinrad, Dehne, Kerstin, Köhler, Jenny, Marshall, John F., Graeff, Henner, Schmitt, Manfred, Reuning, Ute, Lengyel, Ernst

Volltext

Detection and Relevance of Crosslinked Fibrin Derivatives in Blood von Graeff, Henner, Hafter, Reimar

Volltext

Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells von Reuning, Ute, Guerrini, Luisa, Nishiguchi, Tomizo, Page, Sharon, Seibold, Hildegard, Magdolen, Viktor, Graeff, Henner, Schmitt, Manfred

Volltext

Prognostic value of the cysteine proteases cathespins B and cathepsin L in human breast cancer von THOMSSEN, C, SCHMITT, M, GORETZKI, L, OPPELT, P, PACHE, L, DETTMAR, P, JÄNICKE, F, GRAEFF, H

Volltext

Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA) von Kobayashi, H, Schmitt, M, Goretzki, L, Chucholowski, N, Calvete, J, Kramer, M, Günzler, W A, Jänicke, F, Graeff, H

Volltext

Gender differences in myocardial blood flow dynamics : Lipid profile and hemodynamic effects von DUVERNOY, C. S, MEYER, C, SEIFERT-KLAUSS, V, DAYANIKLI, F, MATSUNARI, I, RATTENHUBER, J, HÖSS, C, GRAEF, H, SCHWAIGER, M

Volltext

Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast Cancer von Jänicke, Fritz, Schmitt, Manfred, Graeff, Henner

Volltext

Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasmi... von JÄNICKE, F, PACHE, L, SCHMITT, M, ULM, K, THOMSSEN, C, PRECHTL, A, GRAEFF, H

Volltext